Table 1.
Demographic and clinical data
| Patient | Age | Sex | Disease duration (years) | Scanner | Primarily affected side | FoG |
|---|---|---|---|---|---|---|
| 1 | 75 | male | 12 | A | left | no |
| 2 | 69 | female | 9 | B | left | yes |
| 3 | 69 | female | 11 | A | left | no |
| 4 | 66 | male | 10 | A | left | yes |
| 5 | 72 | female | 11 | A | left | no |
| 6 | 68 | female | 19 | B | left | no |
| 7 | 63 | male | 10 | A | left | yes |
| 8 | 52 | male | 12 | A | left | no |
| 9 | 58 | male | 9 | A | left | no |
| 10 | 58 | female | 11 | B | left | yes |
| 11 | 69 | male | 14 | B | left | yes |
| 12 | 61 | male | 8 | B | NA | yes |
| 13 | 71 | female | 3 | B | NA | no |
| 14 | 65 | male | 15 | B | NA | yes |
| 15 | 66 | female | 14 | A | right | yes |
| 16 | 61 | female | 6 | A | right | no |
| 17 | 63 | female | 9 | A | right | no |
| 18 | 55 | male | 11 | A | right | yes |
| 19 | 55 | male | 9 | A | right | no |
| 20 | 75 | male | 17 | A | right | no |
| 21 | 70 | male | 9 | A | right | yes |
| 22 | 63 | male | 13 | A | right | no |
| 23 | 58 | male | 11 | A | right | no |
| 24 | 60 | male | 4 | A | right | no |
| 25 | 72 | female | 16 | A | right | no |
| 26 | 47 | male | 9 | B | right | no |
| 27 | 61 | female | 9 | A | right | no |
| 28 | 68 | male | 10 | A | right | no |
| 29 | 69 | male | 13 | A | right | no |
Age range (years): 47–75 (mean: 64.1, median: 65.0, standard deviation (SD): 6.93. Gender ratio (♂: ♀): 62%: 38%. Freezing of gait (FOG) ratio (yes:no): 36%: 64%. Scanner A: 3 Tesla Siemens Prisma Scanner (Siemens Healthineers, Erlangen, Germany). Scanner B: 3 Tesla Siemens Skyra Scanner (Siemens Healthineers, Erlangen, Germany). NA: not available.